Cost-Effective Acne and Rosacea Treatment Strategies

Conclusions

• Cost is a major barrier to acne care because many patients skip prescriptions, abandon treatment after prior authorization hassles, and spend substantial amounts out of pocket.
• For mild-to-moderate acne, low-cost generic therapies and combination products are usually high-value first choices because they are effective, convenient, and improve adherence.
• Trifarotene appears to offer little advantage over cheaper retinoids because it is more irritating, more expensive, and not clearly more effective.
• The adapalene/benzoyl peroxide/clindamycin triple-combination product is among the most effective topical options, but its value depends on whether patients can afford it or access assistance programs.
• Tolerability-focused formulations such as tretinoin or tazarotene lotions, clascoterone, and azelaic acid can be especially useful for patients with sensitive skin or pigmentary concerns.
• For moderate-to-severe acne, oral antibiotics remain useful but should be used thoughtfully because resistance and microbiome harms are real, even with lower-dose regimens.
• Sarecycline has a favorable side-effect and microbiome profile, but its high cost means doxycycline is often the better value for most patients.
• Hormonal therapy, especially spironolactone and combined oral contraceptives, is likely underused and can reduce reliance on antibiotics in women with acne.
• Spironolactone is generally effective, usually well tolerated at 100 to 150 mg daily, and does not appear to require routine potassium monitoring in young healthy women.
• Combined oral contraceptives are broadly safe and effective for acne in appropriately selected patients, with relatively small clot and cancer risks that are often outweighed by benefits.
• Routine lab monitoring for isotretinoin, including lipids and liver tests, appears to have limited clinical value in many patients and can often be reduced with shared decision-making.
• Overall acne care should prioritize high-value, patient-centered choices that match treatment to severity, skin sensitivity, and patient goals while minimizing unnecessary cost and monitoring.